DnB Asset Management AS Makes New Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

DnB Asset Management AS bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 23,126 shares of the construction company’s stock, valued at approximately $275,000.

A number of other institutional investors also recently modified their holdings of the company. AlphaQuest LLC lifted its position in Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after buying an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Aspen Aerogels during the fourth quarter worth approximately $164,000. Journey Strategic Wealth LLC bought a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $178,000. Ballentine Partners LLC increased its holdings in shares of Aspen Aerogels by 19.2% in the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock valued at $189,000 after purchasing an additional 2,565 shares in the last quarter. Finally, Aigen Investment Management LP acquired a new stake in shares of Aspen Aerogels in the fourth quarter valued at approximately $219,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Up 0.9 %

Aspen Aerogels stock opened at $6.41 on Thursday. The firm has a market capitalization of $526.29 million, a price-to-earnings ratio of 40.07 and a beta of 2.28. The company’s 50 day simple moving average is $8.71 and its 200 day simple moving average is $14.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels, Inc. has a fifty-two week low of $6.13 and a fifty-two week high of $33.15.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, sell-side analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Analyst Ratings Changes

ASPN has been the topic of a number of recent research reports. Barclays decreased their price objective on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 19th. B. Riley decreased their price target on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a report on Wednesday, February 19th. Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, February 14th. TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Finally, Roth Mkm lowered their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $19.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.